The favorable results obtained with bariatric surgery in the control of type 2 diabetes mellitus (DM2) in morbidly obese individuals and the existence of metabolic control mechanisms independent of weight reduction, have led to the usefulness of various surgical procedures in patients with mild to moderate obesity and even overweight, with the intention of achieving better control of diabetes.

 

Metabolic surgery is defined as those surgical procedures in individuals with a body mass index < 35 kg/m2 with the intention of producing an improvement in the control of diabetes.

​

Recognizing that surgery produces remission of diabetes and that the latter is a continuum, the challenge for the treating team of the patient with DM2 consists in selecting the best medical and/or surgical tool that produces the desired metabolic benefit at a given moment of the disease. evolution of the patient's disease and with a favorable risk-benefit ratio.